On November 7 local time, AstraZeneca held a groundbreaking ceremony for its first manufacturing facility in Singapore. The project's estimated investment amount is $1.5 billion. AstraZeneca stated that after commencing operation in 2029, the Singapore factory will produce antibody-drug conjugates and hire over 800 employees for jobs in engineering, quality, technical services, and global supply chain, among other high-skilled roles.
阿斯利康15亿美元新加坡工厂项目开工，预计2029年投运、创造超800高技能岗位
AstraZeneca's $1.5 billion Singapore factory project has commenced, expected to be operational in 2029, creating over 800 high-skilled jobs.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated